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Abstract 
The three transcription factors, Nanog, Oct-4 and Sox-2, are central regulators of 
pluripotency in embryonic stem cells.  Porcine umbilical cord (PUC) matrix stem cells 
also express these transcription factors. Wharton’s jelly is composed of an extracellular 
matrix high in hyaluronic acid and various collagens and serves as a reservoir for several 
growth factors and cytokines.  We expect that Wharton’s jelly includes a stem cell niche 
that provides a microenvironment that maintains and supports the stem-cell 
characteristics of PUCs.  The mechanisms by which the PUCs remain primitive within 
the Wharton’s jelly are unknown. 
 We developed methods for producing an extracellular matrix product 
extracted from porcine Wharton’s jelly that we named Pormatrix (PMX).  When PMX is 
incubated at 37oC, it becomes a matrical gel that provides a matrix allowing PUC 
attachment and growth.  Concentrating the protein in PMX by filtration provides a low 
molecular weight by-product which we refer to as flow through (FT).  In Experiment 1, 
PUCs were seeded on Pormatrix, Matrigel or plastic substrates in the presence or absence 
of FT.  PUCs cultured on Matrigel, Matrigel+FT, Plastic+FT and PMX had higher 
expression of Nanog compared to PUCs cultured on PMX+FT (P-value <0.05).  
 In Experiment 2, the PMX and Matrigel were diluted to low protein 
concentrations (1.2-1.5 mg/ml protein) so that gelling did not occur.  Adding FT to PMX, 
Matrigel and plastic increased gene expression of Nanog 2.78 fold compared to 
treatments without FT (P =0.10).  Sox-2 expression was increased by adding FT to 
Matrigel but adding FT to the other matrix proteins had no effect resulting in a tendency 
for a matrix*FT interaction(P=0.10). The transcription factor Oct-4 remained unchanged 
regardless of treatment. 
   To evaluate the effects of in vitro maintenance on Nanog, Oct-4 and Sox-2 we 
measured the relative gene expression in PUCs over the first six passages in vitro.  
Nanog, Oct-4 and Sox-2 did not differ over these passages.  This may indicate that during 
 
 the first six passages in vitro, PUCs remain relatively primitive.  In summary, we 
prepared an extract from Wharton’s jelly from porcine umbilical cords.  The extract 
supported PUC attachment and growth and appeared to regulate gene expression.  
Perhaps with further investigation the interactions of PUCs with their in vivo 
environment can be elucidated. 
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CHAPTER 1 - A Literature Review 
Components of the ECM 
 
Mesenchymal cells are embedded in an extracellular matrix that is composed of 
secreted proteins and polysaccharides.  The extracellular matrix (ECM) is responsible for 
filling in the spaces between those cells as well as binding cells and tissues together.  
Epithelial cells secrete an extracellular matrix termed basal lamina.  Basal lamina can 
support epithelial cells, adipose cells, muscle cells and peripheral nerves.  The types of 
connective tissues comprised of extracellular matrix include bone, tendon and cartilage 
(Cooper 2000).The ECM is composed of tough fibrous proteins rooted in a gel-like 
polysaccharide ground substance.  The major structural protein of the ECM is collagen, 
specifically type I or type IV for the basal lamina. Collagen is the single most abundant 
protein in animal tissues constituting about 25% of total protein in animals.  The structure 
of collagen includes a triple helix in which three polypeptide chains (alpha chains) are 
wound tightly around each other.  The three amino acids, glycine, proline, 
hydroxyproline are a combination that stabilize the polypeptide chains to form the triple 
helix of collagen (Cooper 2000). Proline has a ring structure that stabilizes the helical 
conformation and glycine is regularly spaced at every third residue throughout the central 
region of the alpha chain. Glycine is the smallest amino acid and its spatial arrangement 
on the polypeptide chain allows the three helical chains to pack tightly together into the 
“super helix” (Cooper 2000).  It has been observed that the microfibrils of the super helix 
have a right handed super-twist that allows the collagen to interdigitate with neighboring 
microfibrils (Vakonakis 2007).  There are at least 25 different members of the collagen 
family with over 90% of the collagen in the body being types I, II, III and IV with the 
most abundant being type 1 found within skin and bone.   
 
Glycosaminoglycans, or GAGs, create a gel where fibrous structural proteins 
reside (Cooper 2000).  GAGs are polysaccharides that consist of repeating units of 
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disaccharides of hexosamines and hexuronic acid (Jones et al., 1982).  Keratin sulfate is a 
GAG that contains glucosamine and galactose rather than hexosamines and hexuronic 
acid, (Jones et al 1982).  All GAGs except hyaluronan include a sulfate group (Alberts et 
al., 2002).  The other GAGs include chondroitin sulfate, dermatan sulfate, heparan sulfate 
and keratan sulfate.  The GAGs are extremely negatively charged and they bind to 
positively charged ions to trap water molecules for formation of hydrated gels.  The 
hydrated gels that result provide mechanical support to the extracellular matrix (Alberts 
et al., 2002).   
 
Hyaluronan is the only glycosaminoglycan that does not contain a sulfate group.  
It occurs as a single polysaccharide chain.  The other GAGs are linked to proteins and 
form proteoglycans.  Proteoglycans interact with hyaluronan and this forms large 
networks within the ECM (Cooper, 2000).   Because of the hydrated gel consistency of 
hyaluronan it is able to resist compressive forces on tissues and joints (Alberts et al., 
2002).  In embryonic development hyaluronan serves as a space filler to induce a change 
in shape and structure of the developing embryo.  It also serves as a medium for cell 
migration and is produced in large quantities during wound healing (Alberts et al., 2002). 
 
Proteoglycans are important for cell signaling.  For example proteoglycans 
containing heparan sulfate bind to fibroblast growth factors (FGFs).  FGFs stimulate a 
variety of cell types to proliferate (Alberts et al., 2002).  Proteoglycans also have the 
ability to regulate and bind other proteins and influence the fate of those proteins.  
Proteoglycans can immobilize protein at the site where they are produced.    They can 
block the activity of proteins, delay the release of the secreted protein, protect proteins 
from degradation, and alter proteins to make them more effective for presenting to cell 
surface receptors. For example, proteoglycans that branch from heparan sulfate have the 
ability to enable FGFs to activate their cell-surface receptors which in turn increases cell 
proliferation.  Transforming growth factor β (TGF-β) will bind to decorin, a matrix 
proteoglycan, and this action inhibits the activity of other growth factors (Alberts et al., 
2002).     
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The ECM is comprised of glycoproteins that contribute to the organization of the 
matrix and aid in cell attachment.  Glycoproteins tightly bind to collagen, elastin and 
proteoglycans (Jones et al., 1982).  Glycoproteins have binding sites for 
glycosaminoglycans such as heparin sulfate and can react with specific collagen types 
(Jones et al. 1982).  Fibrillin-1 is a multidomain glycoprotein that forms elastic 
microfibrils within the ECM (Vakonakis et al., 2007).  Together with elastin, fibrillin 
provides elasticity and resiliency for a variety of tissues (Vakonakis et al., 2007).  
Fibrillin-1 contains epidermal growth factor-like domains (EGF) as well as TGF-β-
binding protein-like domains (Vakonakis et al., 2007).  
 
 Fibronectin plays a major role in synthesis and composition of the ECM. 
Fibronectin is a dimer composed of two subunits joined by disulfide bonds at one end and 
has binding sites for collagen as well as GAGs to form cross links between these 
components. One of the important roles of fibronectin is attaching cells to the matrix and 
in vertebrate embryos it can guide cell migrations (Cooper, 2000).  Fibronectin stabilizes 
and organizes the matrix (Jones et al., 1982). It is composed of three different domain 
types, FNI, FNII and FNIII (Vakonakis et al., 2007).  The interactions exerted by the 
fibronectin domains and tension exerted through cell-surface receptors are essential 
(Vakonakis et al., 2007).  Fibronectin has mechanical properties allowing living cells to 
stretch the fibril component by as much a four fold (Vakonakis et al., 2007). 
 
Laminin is another glycoprotein that is closely associated with the basal lamina 
and has a less defined function when compared to fibronectin.  Laminin is a large flexible 
protein composed of three polypeptide chains held together by disulfide bonds.  The three 
polypeptide chains are arranged in a manner that resembles an asymmetric cross (Cooper, 
2000). Laminin is confined to the lamina lucida of the basal lamina and is synthesized by 
cultured endodermal cells and endothelial cells.  Basal laminae provide an active barrier 
to the movement of cells and molecules.  It is involved in tissue regeneration after injury 
by serving as a scaffold in which regenerating cells can migrate. Only type IV collagen is 
found in the basal lamina.  Type IV collagen has less organization than type I collagen 
(Jones et al., 1982).  
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 The extracellular matrix is comprised of many different types of macromolecules 
that can influence cell shape, migration, proliferation, survival, development and 
function.  Extracellular matrices influence many cell types including stem cells.  There 
are many types of extracellular matrices that can be produced in vitro and these are useful 
for examining the potential in vivo effects on stem cells (Alberts et al., 2002). 
 
 
Functions of the ECM 
Extracellular matrices provide structural as well as biological support for cells in 
vivo.  Specifically, ECMs function structurally by providing a scaffold for cells, tensile 
strength and cushioning.  The ECM provides a molecular filter, a boundary, a storage 
depot of growth factors and cytokines and can block cryptic sites (Kleinman et al., 2003).  
Biologically the ECM functions in cell polarity, cell adhesion, morphogenesis and 
differentiation, migration, proliferation and prevention of apoptosis (Kleinman et al., 
2003).  The biological responses of the ECM are regulated by cell-surface receptors.  The 
most biologically active ECM molecules include laminins, collagens, thrombospondin as 
well as fibronectin.  The biological importance of the ECM was illustrated in study using 
knock out mice (Kleinman et al., 2003). The mice lacked individual ECM component 
genes. Mice without laminin experienced muscular dystrophy as well as skin blistering 
and the defect is lethal.  Loss of fibronectin results in mesodermal and cardiovascular 
defects and is lethal to the mice as well.  The loss of entactin/nidogen found in basal 
lamina resulted in neurological defects.  Lastly, without collagen there are vascular 
defects, renal failure and ultimately lethality (Kleinman et al., 2003).  Therefore the 
components of the ECM are in a combination that promotes specific biological functions 
and loss of one ECM component can be life threatening and disrupt phenotypes.  The 
ECM macromolecules interact with each other to stimulate and allow important 
biological functions to take place.   
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The basal lamina is the first ECM synthesized in the developing embryo.  
Laminin is expressed at the two cell stage while the basal lamina makes its first 
appearance at gastrulation.  It should be noted that stem cells first come into contact with 
basal lamina during development so it would be safe to assume that ECM has a profound 
impact on the differentiation or maintenance of stem cells.  The basal lamina in vivo is 
enriched with laminin, entactin/nidogen and collagen IV.  Entactin may promote and 
enhance laminin-cell receptor binding and is able to provide a regulated cell-matrix 
interaction (Hagedorn et al., 2001).   
Basement membranes have lesser amounts of proteoglycans and growth factors 
and have the ability to regulate cell polarity (Kleinman et al., 2003).  The basement 
membrane ranges in thickness between about 100 to 300 nm and can be seen with light 
microscopy.  Basal laminae are less than 100 nm in thickness thus can only be seen with 
transmission electron microscopy. The components of basement membranes include 
collagen type IV, laminins and heparan sulfate (Hagedorn et al., 2001).  Basement 
membranes create boundaries between different tissue types and have a specialized 
function in the kidney (Kleinman et al., 2003).  Basement membranes reside underneath 
epithelial cells, around blood vessels and are associated with certain distinct 
mesenchymal cells (Hagedorn et al., 2001).   
 
ECM and tumors 
ECM differs for normal cells and malignant tumors.  Malignant tumors are 
invasive and have the ability to destroy various matrix structures (Hagedorn et al., 2001). 
Tumors cells with the ability to metastasize secrete different amounts of ECM 
components and produce enzymes that degrade the ECM components of the basement 
membrane.  This allows them to invade the different tissues of the body (Jones et al., 
1982).  Basement membranes are usually impenetrable to invasive cells.   The basement 
membrane can be invaded by the action of degrading enzymes secreted by metastazing 
tumor cells (Jones et al., 1982).  The loss of the basement membrane signifies the initial 
step of tumor metastasis (Hagedorn et al., 2001).  A malignant tumor is characterized by 
the ability of tumor cells to invade host tissues, cross basement membranes and to 
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metastasize to distant sites in the body (Jones et al., 1982).  The destruction of the ECM 
occurs in the area of tumors cell in vivo (Jones et al., 1982).  Malignant tumor cells have 
the ability to degrade ECM components through the use of hydrolases.   
 Collagenase is commonly expressed by tumor cells and degrades collagen fibers 
including the collagen IV fibers found in the basal lamina of the basement membrane 
(Jones et al., 1982).  Plasminogen activator is secreted in large amounts by metastatic 
tumor cells as well, but its role and malignant phenotype has not been clearly defined 
(Jones et al., 1982).  There are other degradative hydrolytic enzymes produced by tumors 
and tumor cell lines including cathespins, thiol proteinases and proteoglycan-degrading 
activity (Jones et al., 1982).  Breakdown of connective tissue is very important in the 
invasive process of malignant tumor cells.   
Breakdown of basement membrane material is enhanced by expression of major 
matrix degrading enzymes as well as metalloproteinases (MMPs) (Hagedorn et al., 2001).  
MMPs help degrade the collagenous matrix (Hagedorn et al., 2001).  Different types of 
MMPS are responsible for degrading certain parts of the extracellular matrix.  For 
example, MMPs 1, 8, 13, 18 are collagenases; Gelatinases, (MMP-2 and MMP-9) 
degrade collagen IV and V (Hagedorn et al., 2001).  Stromelysins are responsible for the 
degradation of laminin, fibronectin, and can denature collagens (Hagedorn et al., 2001).  
The molecular alteration of the ECM explains the loss of control of cellular proliferation 
in carcinomas.  Malignant tumor cells destroy components of the ECM and are capable of 
secreting an excessive amount of glycosaminoglycans. 
 
An extracellular component secreted in large quantities by malignant tumor cells 
is hyaluronan (Stern 2008).  Hyaluronan secreted prior to mitosis functions to promote 
detachment of cells to allow motility and this may possibly contribute to the movement of 
metastatic tumor cells (Stern 2008).  It has been hypothesized that cancer cells synthesize 
increased levels of HA in order to detach from their substratum to go through mitosis for 
division, and continue to divide endlessly.  The ability of cancer cells to divide infinitely 
separates them from normal cells that will re-attach to the substratum and continue 
normal functions (Stern 2008).  The inability of cells to shed their hyaluronan coat, via 
hyaluronidase activity, may promote malignant cell growth and the development of 
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cancer (Stern 2008).  Normal cells need to lose their hyaluronan coat in order for 
differentiation to occur.  An increase in hyaluronan is correlated with tumor virulence and 
can be used as a prognostic indicator.  Hyaluronan is produced by cancer cells but 
production is induced by the tumor cells in their surrounding stromal cells (Stern 2008).  
There are other glycosaminoglycans present in cancer cells at abnormal concentrations.  
One such GAG includes heparan sulfate.  Heparan sulfate proteoglycans such as 
syndecans, glypicans and perlecan are associated with tumor progression or suppression, 
and sometimes both (Stern 2008).   
 
Specific ECMs 
The ECM has been studied intensively to assess the biological activity of the 
matrix itself as well as its role in cell differentiation.  The ECM can be studied in vitro 
using three dimensional matrices that are derived from cells or tissues as well as laminin 
or collagen or peptides in the form of proteolytic or recombinant fragments.  Matrigel is a 
matrix derived from the Engelbreth-Holm Swarm tumor found in mice.  Matrigel 
promotes the differentiation of some cell types and can induce growth in cells from tissue 
explants.  When incubated at 37o C for 30 minutes, Matrigel becomes a hydrated gel and 
cells can be plated on top of this matrix.  Matrigel is considered to provide a three 
dimensional matrix that mimics the basal lamina in-vivo.  Stem cells have been cultured 
on Matrigel (Kleinman and Martin 2005). Three dimensional matrices may mimic the in 
vivo environment because cells are suspended and grown in a three dimensional 
environment. 
 
 Cartrigel: An In Vitro ECM 
Philp et al. (2002) created a matrix from an extract of cartilage (Cartrigel) and 
compared the effects of Cartrigel and Matrigel pluripotent rhesus monkey embryonic 
stem (ES) cells grown in a monolayer or in a rotating wall vessel bioreactor (RWV).  The 
results indicate that Matrigel, as a solution or as a gelled substrate, induced cell growth 
and differentiation.  Large tubular-like structures and cell aggregates were observed for 
cells grown on Matrigel.  By day 11, the cells grown on Matrigel continued to form large 
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organ-like tubular structures.  Cells grown in RWV bioreactors using soluble Matrigel 
became cell aggregates with increased size and also differentiated into highly organized 
tubular- and glandular-like structures.  Cells grown on Cartrigel as a gel or as a solution 
grew as a monolayer in vitro.  In the RWV bioreactor Cartrigel, increased the cell number 
was but had no obvious effects on differentiation.   
Matrigel was able to promote epithelial/glandular-like structures while Cartrigel 
promoted chondrogenesis with round cartilage nodules visible among the undifferentiated 
stem cells.  In the RWV bioreactor, Matrigel produced greater differentiation compared 
to Cartrigel (Philp et al., 2002). 
 
 Humatrix: Myoepithelial Derived ECM 
A myoepithelial-derived matrical gel termed Humatrix was prepared by 
Kedeshian et al. (1998) to observe the relationship between carcinoma cells and the 
extracellular matrix in vivo.  Humatrix is prepared from salivary gland and breast 
myoepithelial tumors.  It is physically similar to Matrigel in that gelation occurs at 25-37o 
C when the protein concentration is greater than or equal to 3 mg/ml.  A major difference 
between the two matrices is that Matrigel extraction yielded 9 mg/ml protein/g of 
Engelbreth Holm-Swarm (EHS) tumor and Humatrix yielded only 1.5mg protein/g of 
human matrix secreting xenografts from salivary gland (HMS-X).  Protein analysis 
indicated that fibronectin and type I collagen bands are predominate in Humatrix whereas 
Matrigel has more laminin and type IV collagen.  Both matrices have comparable 
glycosaminoglycan content but Humatrix has a large amount of chondroitin sulfate and 
Matrigel has more heparan sulfate.  Humatrix contains EGF and IGF-I but lacks TGF-β.  
Humatrix seeded with metastatic non-myoepithelial cells from a human melanoma line 
and a breast carcinoma line demonstrated reduced invasion, angiogenesis and metastasis.  
Myoepithelial cell lines established from benign human salivary gland and breast 
myoepithelial tumors resulted in tumorigenicity when seeded on Humatrix.  The 
tumorigenic effect of Humatrix may be due to its specific extracellular matrix synthesized 
from myoepithelial carcinomas or the composition of growth factors within the matrix 
itself or both. Humatrix is considered to be a tool that can be used to observe biological 
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processes of tumor cell growth, angiogenesis, invasion and metastasis (Kedeshian et al., 
1998). 
 
Synthetic Matrices 
Synthetic matrices have also been studied for their effects on cells.  The use of 
synthetic ECM may aid in stem cell self renewal.  Li et al. (2006) created a hydrogel 
composed of a semi-interpenetrating polymer network (sIPN).  The sIPNs consisted of 
poly (N-isopropylacrylamide-co-acrylic acid) [p (NIPAAm-Co-AAc) which was loosely 
cross-linked with an acrylated peptide; Gln-Pro-Gln-Gly-Leu-Ala-Lys-NH2.  This was 
interpenetrated by a polyacrylic acid-graft linear polymer chain, [p (AAc)-g-RGD].  The 
RGD motif present in the polyacrylic acid-graft is an active site in many ECM proteins 
and a binding domain for cellular integrins.  The sIPNs used in this study were 
hydrophilic and became hydrated in aqueous media.   
The ability of the hydrogel to become hydrated mimics in vivo ECMs.  Important 
characteristics of the hydrogel are the abilities to manipulate matrix stiffness and to 
control cell-adhesion ligand density.  These two things regulate cell adhesion, migration 
and differentiation.  When human embryonic stem cells (hESCs) were cultured on the 
sIPN hydrogel they maintained their original phenotype as evidenced by cell 
morphology.  The cells had distinct colony borders surrounded by small tightly packed 
cells.  Oct 4and SSEA-4 (a cell surface antigen also expressed in undifferentiated hESCs) 
were observed for cells grown on the sIPN on day 5 of culture.  The authors also assessed 
whether ligand concentration had an impact on hESC cell growth on the sIPN.  Higher 
RGD concentrations resulted in morphologies characteristic of undifferentiated hESCs, 
including distinct colony borders with small tightly packed cells within the colony.  
Whereas cells grown on sIPNs with lower RGD concentrations had low hESC adhesion 
(Li et al., 2006) 
 
Levenburg et al. (2003) created a three dimensional, porous, biodegradable 
polymer scaffold.  hESCs were plated on the polymer scaffold or Matrigel.  The polymer 
scaffold was designed to resist compressive stress exerted by the cells.  By introducing 
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different growth factors to the polymer scaffold different structures could be grown.  The 
polymer scaffold was fabricated from a blend of 50% poly (lactic-co-glycolic acid) 
PLGA and 50% poly (L-lactic-acid) PLLA.  PLGA degrades quickly while PLLA gives 
the scaffold its stiffness.  The pore size of the scaffold is between 250-500um to help 
facilitate the seeding and growth of the cells into the polymer scaffold.   
Both Matrigel and the polymer scaffold supported cell attachment, growth, and 
viability.  The polymer scaffolds were supplemented with various growth factors 
including retinoic acid (RA), activin-A, TGF-β and IGF-1.  The scaffold supplemented 
with IGF-1 resulted in cells forming large open tubular structures that had a cuboidal, 
columnar epithelial morphology.  Supplementing the scaffold with RA increased the 
cytokertain positive areas and the cellular structures secreted extracellular matrix 
components.  The addition of TGF-β to the scaffold resulted in the secretion of a 
cartilage-like glycosaminoglycan matrix.  Supplementation of either activin-A or IGF 
resulted in the formation of structures similar to developing liver and cells contained high 
levels of alpha-fetoprotein and albumin.  The ability of the scaffold to induce 
vascularization was determined using histology and immunohistochemical staining. 
Capillary like networks were formed within the scaffolds with cells that expressed the 
endothelial markers CD34 and CD31.  Formation of vessel like structures in the Matrigel 
coated scaffold occurred with higher expression on the control scaffold and the scaffold 
supplemented with IGF-1.  Scaffolds coated with fibronectin had higher levels of 
endothelial differentiation and vascularization regardless of growth factor 
supplementation. 
 
The therapeutic potential of the polymer scaffolds was tested in the subcutaneous 
tissues of severe combined immunodeficiency deficient (SCID) mice.  Implanted 
scaffolds were retrieved 2 weeks later and the cells growing in the constructs were viable, 
and there were no detected inflammatory responses to the scaffold.  The implants were 
loosely surrounded by connective tissue and had been penetrated with host blood vessels.  
Red blood cells were within the construct-derived blood vessels suggesting that 
anastomosis between the construct and the host vessels occurred (Levenburg et al., 2003).  
Other in vitro studies have shown that both Matrigel and collagen gels can induce 
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capillary-like formation of endothelial cells (Kleinman et al., 2003) as may have been 
observed here.  
 
  It was observed that cells continued to differentiate within the host after 
transplantation as evidenced by the lack of SSEA-4 and Tra-1-60.  Therefore a polymer 
scaffold seeded with early differentiating hESCs results in the formation of three-
dimensional structures of human cells.  Important characteristics of the polymer scaffold 
are its abilities to biodegrade within the host, to support viability of the differentiating 
cells, and to vascularize (Levenberg et al., 2003).  
 
Stem cell responses to ECM 
Stem cells respond differently to the different types of ECM, (see table 1.1).  
Tissue-specific matrices such as Humatrix may be able to manipulate development of 
cancer cells in tumors whereas Matrigel influences cells to readily differentiate into organ 
like structures.  Some matrices allow stem cells to self renew and maintain potency while 
others induce differentiation into different cell lineages.  
 
Potency  
Stem cells are primitive cells found in various tissues of the human body and have 
varying degrees of potency.  During embryogenesis, the inner cell mass of the blastocyst 
is composed of totipotent stem cells.  These cells have the ability to become any 
specialized cell type of the body including extraembryonic membranes.  Other potencies 
include pluripotency or the ability of a stem cell to give rise to the three germ layers, 
endoderm, ectoderm and mesoderm.  Multipotency is the ability to become a specialized 
cell from a specific tissue layer.  For example, mesenchymal stem cells, isolated from 
post-natal tissue, can give rise to adipose tissue, bone marrow and chondrocytes all of 
mesodermal lineage.  Spermatogonial stem cells are an example of unipotent stem cells 
because give rise to one specialized cell type, the spermatozoa. 
Umbilical cord matrix stem cells 
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The umbilical cord serves as a link between mother and fetus during gestation.  
The umbilical cord is composed of separate compartments including: the surface 
epithelium, perivascular stroma, intervascular stroma (Wharton’s jelly), clefts, 
subamnion, umbilical vein subendothelium and the umbilical cord blood (Can et al., 2007 
and Troyer and Weiss 2008).  Clefts as described by Nanaev et al. (1997) are within the 
Wharton’s jelly and occupied by a homogenous ground substance, now understood to be 
collagen. Clefts are devoid of collagen fibrils and basal lamina molecules.  Clefts are 
thought to contribute to the turgor of the cord (Can et al., 2007). The structure of the 
umbilical cord includes two arteries and one or two veins depending on the species.   
The vessels are surrounded by Wharton’s jelly.  Umbilical arteries carry the lower 
oxygen fetal blood to the placenta and the vein(s) carry oxygenated, nutrient-enriched 
blood to the fetus (Rao et al., 1994). Wharton’s jelly was first described by Thomas 
Wharton in 1656 (Sarugaser et al., 2005).  Wharton’s jelly is an embryonic mucous 
connective tissue that lies between the umbilical cord vessels and is covered by the 
amniotic epithelium.  The physiological roles of Wharton’s jelly are to prevent tearing 
and bending of the enclosed vessels and serve as an adventitia to bind and encase the 
umbilical vessels.  Wharton’s jelly is comprised of specialized fibroblast-like cells and is 
rich in proteoglycans of which hyaluronic acid is the quantitatively predominant species 
(Can et al., 2007).  The large amount of hyaluronic acid within the umbilical cord keeps 
the tissue hydrated and the large amount of collagen makes the cord resistant to extension 
and compression induced by the fetus and by contraction during delivery (Malkowski et 
al., 2007).  Stern et al. (2008) supports the notion that hyaluronan is a major constituent 
of fetal structures including Wharton’s Jelly.   
The stromal cells of the umbilical cord are responsible for synthesis of collagen as 
well as other matrix components.  The cells are partially covered by external lamina 
composed of, laminin, collagen type IV and heparan-sulfated proteoglycan (Can et al., 
2007).    The external lamina of stromal cells in the umbilical cord is similar to the 
sarcolemma of smooth muscle cells.  The stromal cells within the Wharton’s jelly contain 
subplasmalemmal and intracytoplasmic focal dense plaques typical of smooth muscle 
cells, but they are defined as myofibroblasts.  Myofibroblasts share features with both 
fibroblasts and smooth muscle cells.  
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A Stem-Cell Niche in Wharton’s Jelly 
The cytokines and growth factors that reside in the Wharton’s jelly of the 
umbilical cord may collectively constitute a niche in which umbilical cord matrix stem 
cells (UCMS cells) are able to communicate and their division, maintenance, and perhaps 
differentiation are supported and regulated.  It may be that the entire Wharton’s jelly 
compartment provides a stem-cell niche or there may be sub-compartments that regulate 
the cells differently and perhaps even sequentially.  Alp Can et al. (2007) demonstrated 
differences in the differentiation state and other properties of UCMS cells in the 
perivascular compartment as compared to those deeper in Wharton’s jelly.  This could 
indicate a ‘production line’ with cells deep in Wharton’s jelly maintaining and providing 
stem cells to replace transient amplifying cells near the vasculature.  Such a system could 
provide mesenchymal stem cells to the vasculature or perhaps to the whole fetal-placental 
unit during pregnancy.  Support for this idea would require identifying sub-environments 
within the umbilical cord that provide signals and support for pluripotency or 
multipotency. 
 
Regardless, the Wharton’s jelly of the umbilical cord, as a site of stem-cell 
residence, must contain a stem-cell niche according to current concepts. A stem-cell 
niche is defined as a specialized microenvironment that supports stem cells and varies in 
nature depending on the tissue type (Li and Williams., 2006; Peerani et al., 2007).  
Anatomically, the stem cell niche is a space where molecular interactions guide spatial 
relationships (Scadden et al., 2007).  There are several common themes our present 
understanding identifies for stem cell niches.  One theme is that the niche is composed of 
cells in a special location that functions to maintain stem cells (Li et al., 2006).  The 
special location in the umbilical cord is the Wharton’s jelly or a compartment of it, and 
the cells that maintain stem cells may be other UCMS cells or a subpopulation of them.   
The stem cell niche in Wharton’s jelly constitutes a three dimensional scaffold that 
  13
harbors collagens, fibroblasts, immune cells, growth factors and cytokines and gives 
physical support to the UCMS cells (Troyer and Weiss 2008). 
 
Another theme considered important for a stem-cell niche is that adhesion 
molecules in the ECM anchor the stem cells to the matrix and allow for niche-stem cell 
interaction (Li et al., 2006).  Collagens are components of the ECM important for the 
anchoring of cells to the niche.  In Wharton’s jelly, a variety of collagens constitute the 
ECM including type 1, IV, V, IV and VII (Franc et al., 1998; Ryynanen et al., 1993). The 
fibrillar and microfibrillar constituents of Wharton’s jelly include 67-nm striated collagen 
fibrils but fibrils range from 30 to 60 nm (Franc et al., 1998).  The 67-nm striated 
collagen fibril is most abundant within the Wharton’s jelly.  The striated fibrils have a 
100 nm banding pattern characteristic of type VI collagen. Collagen VI may play a role in 
the anchorage of the cells of the Wharton’s jelly or mediate the linkage between the main 
fibrillar matrix components and hyaluronic acid (Franc et al., 1998). 
 
Another collagen type associated with Wharton’s jelly is type VII collagen. Type 
VII collagen is a homotrimer with the suggested form being an anti-parallel dimer 
associated through an overlap region between individual molecules. The anti-parallel 
dimers aggregate laterally to form anchoring fibrils.  Type VII collagen has been found in 
basement membranes of the epithelia of organs such as breast, prostate, bronchi, larynx, 
esophagus, trachea, and vagina.  Type VII collagen is predominately associated with 
keratinocytes and to a lesser extent, dermal fibroblasts.  Ryynanen et al. (1993) examined 
the localization and spatial orientation of type VII collagen gene expression in the human 
umbilical cord.  The findings demonstrated that cells cultured from the Wharton’s jelly 
have prominent staining for type VII collagen.  The endothelial cells from the vein of the 
umbilical cord had weak, but detectable immunoreaction for Type VII collagen.  
Northern analyses revealed that cells from Wharton’s jelly also express type VII collagen 
epitopes and high levels of mRNA.  Collagens make up the frame of the ECM and may 
anchor stem cells or supportive cells to the niche to allow interaction between the cells 
and extrinsic factors. 
 
  14
In the umbilical cord, Wharton’s jelly is the ECM and serves an anchorage 
function and allows for communication between the niche and stem cells. The matrix 
components of the ECM anchor the cells in the niche environment and could exert 
influences on the stem cell population that either stimulate or inhibit behaviors 
(Nurcombe et al., 2007). The stem cells may interpret signals received directly from the 
components within the matrix.  One such component is heparan sulfate (HS).  HS is a 
glycosaminoglycan that can form sugar-protein complexes, known as HS proteoglycans.  
The three major forms of HS proteoglycans are the syndecans, glypicans and perlecans 
(Nurcombe et al., 2007).  Syndecans are cell membrane-intercalated proteoglycans; 
glypicans are membrane-associated and perlecans are secreted from the ECM itself.  HS 
regulates a variety of growth factors and adhesive factors within the ECM that act on the 
surrounding cells.  For example, FGF family is able to bind to HS with moderate affinity.  
Through binding with HS, the FGFs bind to their cell surface tyrosine kinase receptors 
allowing signal transduction to occur (Nurcombe et al., 2007). A similar scenario occurs 
between HS and bone morphogenetic proteins (BMPs).   HS concentrates growth factors 
close to the cells, and may protect them from proteases, guides them to the cell surface 
and facilitates binding to their specific cell receptors (Nurcombe et al., 2007).   
 
A third theme is that extrinsic factors in the stem cell niche are responsible for 
controlling stem cell number, proliferation, and fate and it is generally believed that these 
factors are produced locally.  Many extrinsic factors have been shown to play a role in 
stem cell self-renewal and differentiation including hedgehog, Wnts, BMPs, FGFs, and 
Notch (Li et al. 2006).  Hedgehog proteins are important in regulating the development of 
many tissues and organs and Wnt proteins are essential in embryonic and fetal 
development.  The spatial arrangement of stem cells and support cells within the niche 
organizes the timing and secretion levels of signal(s) that stem cells receive which in turn 
directs the fate of the cell (Peerani et al., 2007).   
Stem cells undergo two types of cell division.  Symmetrical division results in 
production of two identical daughter cells and asymmetrical division produces one 
daughter cell that remains a stem cell in the niche but the other daughter is destined for 
differentiation.  The niche controls the balance between symmetrical and asymmetrical 
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division to provide stem cell self renewal or stimulate differentiation (Li et al., 2006).  
According to Scadden et al. (2006), polarity of the stem cell to the niche and the 
orientation of the stem cell niche are critical for determining which type of division stem 
cells will undergo.   
 
Uncontrolled proliferation of stem cells can lead to tumorigenesis and this is why 
it is crucial that the niche closely regulates stem cell division.  The stem-cell niche 
regulates stem cell division and communication with the ECM.  These niche features are 
extracellular and result in gene regulation to provide for either stem cell maintenance or 
differentiation.  At the nuclear level, transcription factors form regulatory circuits that 
control stem cells.  
 
Growth Factors and Cytokines Within the Niche 
The extracellular matrix of the Wharton’s jelly serves as a reservoir for an array 
of growth factors and cytokines with known roles in growth and development (see table 
1.2). The Wharton’s jelly extracellular matrix may be capable of controlling growth 
factor signaling (Sobolewski et al., 2005).  The growth factors within the Wharton’s jelly 
of the umbilical cord are known to control cell proliferation, differentiation and synthesis, 
and remodeling of the extracellular matrix (Sobolewski et al., 2005).  Most of the growth 
factors characterized within the umbilical cord exert their regulatory end product by 
autocrine or paracrine action (Sobolewski et al., 2005).   
 
One growth factor found in human Wharton’s jelly, that can function by a 
classical endocrine mechanism is IGF-1.  IGF-1regulates metabolic activity and is 
involved in cell growth and differentiation (Palka et al., 2000).  It stimulates collagen and 
sulphated GAGs biosynthesis and is expressed in most fetal tissues (Palka et al., 2000).  
IGF-1 is expressed by cells of mesenchymal origin and expression is independent of 
growth hormone (Palka et al., 2000).  IGFs are associated with extracellular binding 
proteins (IGF-BPs) that regulate IGF tissue activity.   IGF-BPs are found in Wharton’s 
jelly (Palka et al., 2000).  Palka et al. (2000) and others observed that IGF-1 is expressed 
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almost 3 times more in the Wharton’s jelly compared to umbilical cord serum. Adding 
IGF-1 to culture media benefits human embryo development by increasing the 
blastulation rate (and increasing the number of cells in the inner cell mass (Sjoblom et al., 
1999).  
 
Transforming-growth factor-β is expressed within the umbilical cord  TGF-β 
signaling is mediated through binding to cell-surface type I and type II receptors 
containing threonine/serine kinase activity (Peerani et al., 2007).  It has been noted that 
the high expression of TGF-β may result in a reduction in pre-eclampsia.  TGF-β binding 
proteins are found in Wharton’s jelly and are structurally similar to fibrillin.  The TGF-β 
binding proteins are responsible for storing TGF-β in the ECM (Sobolewski et al., 2005).  
 
 Platelet-derived growth factor (PDGF) is a protein that binds to a secreted protein 
acidic and rich in cysteine (SPARC) (Sobolewski et al., 2005).  SPARC is a pericellular 
matrix protein and is expressed during development particularly when tissues are 
undergoing remodeling or repair (Sobolewski et al., 2005).  Epidermal growth factor 
(EGF) is also present in the Wharton’s jelly and binds to decorin, a proteoglycan present 
in the extracellular matrix (Sobolewski et al., 2005).  Epidermal growth factor and 
transforming growth factor-α are present in amniotic fluid as well as fetal blood (Rao et 
al., 1995).  
 
Rao et al. (1995) has shown that EGF, TGF-α, and their receptor mRNA 
transcripts can be found in the human umbilical cord.  More specifically, the transcripts 
have been found in the umbilical cord vessels, Wharton’s jelly, and umbilical amnion 
having the highest expression (Rao et al., 1995).  EGF is a powerful mitogen and 
promotes cells to grow, differentiate, and is essential in embryogenesis and important in 
wound healing.  TGF-α binds to the EGF receptor and in doing so stimulates the growth 
of endothelial cells. The activation of EGF and TGF-α results in a modest increase in 
COX-1 and COX-2 genes (Rao et al., 1995).  Products of these two genes are responsible 
for catalyzing the formation of PGH2.  EGF and TGF-α have also been shown to induce 
PGE2.  PGE2 is of significant importance because it constricts umbilical blood vessels 
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and may help to maintain a steady supply of blood between mother and fetus (Rao et al., 
1995).  Likewise, EGF and TGF-α may have the ability to constrict the umbilical cord 
blood vessels immediately after delivery of the fetus to prevent bleeding from the fetus 
Fibroblast growth factors (FGFs) are a group of cytokines important in 
development, wound healing, hematopoiesis and tumorigenesis (Malkowski et al., 2007).  
Two types of FGFs have been associated with the umbilical cord, acidic FGF (aFGF) and 
basic FGF (bFGF).  These two factors regulate cellular functions through four distinct 
membrane receptors that have tyrosine kinase activity (Malkowski et al., 2007; Peerani et 
al., 2007).  FGFR 1 is the most abundant FGF receptor in undifferentiated human ES 
cells (Liu et al., 2006).  Stabilization by cell-surface heparan-sulfate proteoglycans 
(HSPGs) allows FGF to bind to FGFR (Peerani et al., 2007).  FGFs act mainly through 
paracrine action and the large amount of FGFs present in the Wharton’s jelly may result 
in synthesis of extracellular matrix components and stimulation of cell division 
(Malkowski et al., 2007).  The high concentration of FGFs in Wharton’s jelly is crucial in 
regulating the physiological functions of stem cells (Malkowski et al., 2007).  It appears 
that bFGF signaling is important to human ES cell self-renewal (Liu et al. 2007).   
 
Two other cytokines synthesized within the Wharton’s jelly of the umbilical cord 
are granulocyte macrophage stimulating factors (GM-CSF) and granulocyte colony 
stimulating factors (G-CSF) (Troyer and Weiss 2008 and Wang et al. 2008). GM-CSF 
was originally identified as a product of activated T-lymphocytes and is involved in the 
proliferation and differentiation of myeloid hematopoetic cells (Sjoblom et al., 1999).  It 
is reported that GM-CSF can act as a survival factor for the developing embryo (Sjoblom 
et al., 1999).  Human blastocysts cultured with GM-CSF have a higher number of cells in 
the inner cell mass (Sjoblom et al., 1999).  For mouse blastocysts, GM-CSF promotes the 
uptake of glucose through binding to trophectoderm cells via the α chain of the GM-CSF 
receptor (Sjoblom et al., 1999).  The increased glucose may stimulate metabolic activity 
and cell division.  An important factor for maintaining undifferentiated spermatogonial 
stem cells is glial-derived neurotrophic factor (GDNF) and GDNF is secreted by UCMS 
cells in Wharton’s jelly (Troyer and Weiss 2008).   
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IGF, FGF AND TGF-β Regulate the Stem Cell Niche 
A study conducted by Bendall et al. (2007) examined the effects of IGF and FGF 
production and inhibition on the stem cell niche and their role for the survival and self-
renewal of pluripotent hESCs.  Using immunocytochemistry, it was observed that IGF1R 
is expressed exclusively by Oct4 + cells within hESC colonies (Bendall et al., 2007).  In 
contrast, FGFR1 expression was limited to cells surrounding the Oct 4+ stem cell 
colonies. When Bendall and colleagues blocked the IGF pathway in hESCs cell 
expansion stopped.  A decrease in the number of cells expressing SSEA-3, a stem cell 
marker, was also observed after blocking the IGF pathway.  Blocking the FGF pathway 
through its receptor resulted in increased differentiation of the hESCs, but did not affect 
cell number.  This suggests that perhaps FGF has an indirect role in the hESCs 
maintenance.  Inhibiting TGF-β signaling increases differentiation, without affecting cell 
number, apoptosis or cell cycle status regardless if the cells are SSEA3+ or SSEA3-.  
TGF-β expression is induced by FGF in hESCs cultures.  This indicates that FGF may 
indirectly work with TGF-β to maintain pluripotency in stem cells (Bendall et al., 2007).  
Because IGF, FGF and TGF-β are in Wharton’s jelly they may participate in the stem cell 
niche for UCMS cells. 
 
 
Transcription Factors Oct4, Nanog and Sox 2 
The three transcription factors demonstrated in pig UCMS cells are Oct 4, Nanog 
and Sox 2 (Carlin et al., 2006).  In ES cells, these transcription factors are responsible for 
maintaining potency and self renewal. Expression of these transcription factors activates 
self renewal genes and represses genes responsible for cell differentiation (Liu et al., 
2007).  Oct 4 is a POU-domain transcription factor and is expressed in the nuclei of all 
cells during the cleavage stage in embryogenesis (Roberts et al., 2004). In the blastocyst 
stage, before implantation, expression of Oct 4 is restricted to the inner cell mass.  Oct 4 
is down-regulated during the blastocyst and gastrulation stages as somatic lineage 
differentiation begins (Guo et al., 2002).  If Oct 4 is down-regulated in the inner cell 
mass, all the cells of the embryo differentiate into trophectoderm (Roberts et al., 2004).  
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As stem cells lose their pluripotency, Oct 4 becomes down regulated (Liu et al., 2007).  
Over expression of Oct 4 can lead to differentiation as well (Pan et al., 2007).  Therefore 
an embryo must regulate expression of Oct 4 to maintain pluripotency of the inner cell 
mass.   
 
The high mobility group (HMG) factor, Sox 2, is also crucial for maintaining 
pluripotency in stem cells (Pan et al., 2007).  During early development, Sox 2 has a 
similar expression pattern to Oct 4.  Deletion of Sox 2 results in failure of the embryo to 
undergo implantation but it does not prevent blastocyst formation and differentiation into 
the trophectoderm (Roberts et al., 2004).  Sox 2 together with Oct 4 regulate the 
production of FGF4 by the epiblast (Roberts et al., 2004).  FGF 4 is necessary for 
trophectoderm proliferation (Roberts et al., 2004).  Together the transcription factors Oct 
4 and Sox 2 are a heterodimer that regulates downstream genes and also regulates the 
expression of Oct 4 and Sox 2 genes (Liu et al., 2007).   
 
Nanog, the third transcription factor found in ES and UCMS cells, is also a target 
of the Oct4/Sox 2 complex (Liu et al., 2007).   Nanog is a homeobox-containing factor 
that is crucial for maintaining pluripotent cells of the inner cell mass and ES cells (Liu et 
al., 2006). Nanog expression is essential for preventing differentiation of the ICM and ES 
cells into primitive endoderm (Pan et al., 2007).  Nanog is absent in cells that have 
undergone differentiation (Liu et al., 2007).  It is first detected in the cells of the 
compacted morula in the mouse, but expression is then confined to the inner cell mass 
and disappears in the trophectoderm in the blastocyst stage (Pan et al., 2007).  As Nanog 
expression is further down-regulated it is restricted to the epiblast and barred from the 
primitive endoderm (Pan et al., 2007).  Nanog is also expressed in primordial germ cells 
and this expression spans the period of epigenetic erasure and germ-cell commitment 
(Chambers et al., 2007).  During embryogenesis, if Nanog is not expressed, embryonic 
mice fail to develop after the blastocyst stage and do not contain an epiblast (Pan et al., 
2007).  Down-regulation of Nanog may predispose cells to differentiate, but cells can 
remain indefinitely in the pluripotent state in its absence.  Perhaps Nanog is needed for 
  20
the synthesis of the inner cell mass and construction of germ cells but is not the primary 
force driving pluripotency (Chambers et al., 2007).  
 
The three transcription factors work synergistically to maintain pluripotency 
within the inner cell mass of the blastocyst.  The three factors co-occupy the promoters of 
many of the same genes (Pan et al., 2007).  For example in the mouse, Sox 2 binds to half 
of the genes bound by Oct 4 and more than 90% of the promoter region bound by both 
Oct 4 and Sox 2 are also bound to Nanog.  In undifferentiated embryonic stem cells, 
Oct4, Nanog, and Sox 2 simultaneously bind to 352 genes (Pan et al., 2007).  It has also 
been observed that Oct 4, Nanog and Sox 2 form an interconnected auto-regulatory loop 
by binding to their own promoters and this further maintains ES cell pluripotency 
(Pereira et al., 2006, Pan et al., 2007, Cole et al., 2008).  The transcription factors that 
control stem cell pluripotency need to be strictly controlled to balance stem cell self 
renewal and differentiation into another lineage.   
Methods for harvesting UCMS cells 
There are several ways to isolate UCMS cells from the Wharton’s jelly.  Usually 
the arteries and veins are removed and discarded.  Collagenase-containing solutions can 
be used to digest the umbilical cord and isolate the cell explants for culture (Can et al., 
2007).  The collagenase solution degrades the matrix ground substance and shortens the 
time for the isolation process.  Carlin et al. (2006) collected term, midgestation, and early 
gestation porcine umbilical cords rinsed them in PBS and cut them longitudinally into 1-
3cm segments.  The arteries and veins were removed and discarded and the remaining 
tissue, Wharton’s jelly, was removed using hemostats and surgical scissors.  To isolate 
and culture the porcine UCMS cells, (PUCS) the Wharton’s jelly explants were cultured 
in 6 well plates with DMEM and 20% FBS.  After 24-48 hours adherent PUCS were 
observed.  The morphology of PUCS is spindle-shaped and they form colonies of tightly 
packed round small cells with a high nucleus to cytoplasm ratio.  This morphology is 
characteristic of UCMS cells from other species.   
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Total RNA was extracted from the PUCS and RT-PCR revealed expression of 
Nanog, Oct 4, and Sox 2 (Carlin et al., 2006).  Quantitative RT-PCR was also conducted 
to determine the relative expression of the three transcription genes isolated from PUCS.  
A higher level of mRNA expression of Nanog was present in the PUC cells compared 
with Oct 4 and Sox-2 (Carlin et al., 2006).  UCMS cells from some species do not 
express Oct 4 but expression of Nanog and Sox 2 appears to be a characteristic of all 
species studied to date (Can et al., 2007).   
 
UCMS vs. MSCs 
UCMS cells are mesenchymal-like stem cells (MSCs).  They fit the criteria used 
to define adult MSCs and have some genetic markers and surface markers that are 
common to MSCs (Can et al., 2007; Troyer et al., 2008).   
 
The adhesion molecules CD44, CD105 and integrin markers CD29 and CD51 as 
well as the markers CD10, CD13, CD29, CD44, CD105, CD73, and CD90 characterize 
MSCs and are consistently found in human MSCs (Can et al. 2007; Troyer et al., 2008; 
Wang et al., 2004).  UCMS cells also express the MSC markers SH2 and SH3 (Wang et 
al., 2004).  MSCs lack hematopoietic stem cell markers such as CD45, CD34, and human 
leukocyte antigen (HLA)-DR and this is consistent with UCMS cells (Can et al., 2007).  
Even though stem cells isolated from Wharton’s jelly share MSC markers they have 
faster proliferation and greater in vitro expansion than bone marrow MSCs (BMSCs) 
(Baksh et al., 2007; Troyer et al., 2008).  MSCs were originally isolated from marrow of 
the bone and have been applied to cell based therapies (Baksh et al., 2007; Wang et al., 
2004).  UCMS cells express the stem cell factor gene while BMSCs do not (Troyer et al., 
2008).  CD146 and CD117 have higher levels of expression in UCMS cells than BMSCs 
(Baksh et al., 2007).   
 
MSCs are multipotent cells that can be derived from bone marrow and fat and can 
self-renew and differentiate into specialized cells in vitro (Troyer et al., 2008).  MSCs 
can also be derived from dental pulp, placenta, umbilical cord blood and fetal tissues such 
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as spleen, lung, pancreas, kidneys and amniotic fluid from midgestation (Secco et al., 
2008).  The MSCs are multipotent and can differentiate in vitro into bone, muscle, 
adipose tissue, cartilage and tendon and there is evidence that they can become neural 
cells as well (Wagner et al., 2007; Troyer et al., 2008).  This is also consistent with 
UCMS cells can differentiate into all the specialized cells listed above and more.  In fact, 
UCMS cells also differentiate into osteocytes faster than BMSCs and generate 
significantly more adipocytes than BMSCs (Baksh et al., 2007).  MSCs are plastic 
adherent cells that can be maintained in culture conditions (Wagner et al., 2007).  The 
morphology of MSCs is large spindle-shaped cells, flat cells and small subpopulations 
(Wagner et al., 2007).  This is comparable to the morphology of UCMS cells. UCMS 
cells also adhere to plastic wells and grow to confluency in culture conditions.   
 
For MSCs isolated from BM the cell numbers decrease significantly with age, 
while UCMS cells can be cultured for longer periods of time (Baksh et al., 2007; Secco et 
al., 2008).  MSC can also be isolated from umbilical cord blood but it has been shown 
that perhaps the more efficient ways to obtain mesenchymal like stem cells is through the 
umbilical cord stroma, not the blood (Secco et al., 2008). 
 
Differentiation Potentials of UCMS Cells 
Investigators believe that UCMS cells are comparable to MSCs because of their 
ability to differentiate into osteogenic, adipogenic, chondrogenic and other specialized 
cells in vitro and in vivo (Can et al., 2007 and Wang et al., 2004 and Karahuseyinoglu et 
al., 2007 and Conconi et al., 2006 and Wu et al., 2007). 
 
 Based on morphology there are two types of cells isolated from Wharton’s jelly; 
Type 1 and Type 2 (Karahuseyinoglu et al., 2007).  Type 1 cells appear flattened and 
fiber rich while type two cells are more fusiform in shape and have cytoplasmic 
extensions.  Type 1 cells strongly express vimentin and pancytokeratin while type 2 cells 
express only vimentin, hUMSCs were able to differentiate into chondrocytes, adipocytes, 
and osteocytes, as well as.  Isolated stem cells from the umbilical cord formed spherical 
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shiny surfaced cell masses within 3 weeks of inducing culture media.  The cells stained 
with toluidine blue which is an indicator for accumulation of mucopolysaccharides, the 
dominant molecule in chondrocytes (Karahuseyinoglu et al., 2007).  With the use of 
alcine blue staining, Wang et al. (2004) observed differentiation of UCMS cells into 
chondrocytes.    
 
In the study carried out by Karahuseyinoglu et al. (2007) adipogenic 
differentiation occurred within 40 days of isolation in inducing medium.  The observation 
of adipocytes was first signaled by the appearance of multi-sized, tiny intracytoplasmic 
lipid droplets inside the fusiform shaped cells.  The cells became more cuboid shape and 
lipid granules tended to fuse together creating larger granules. Wang et al. (2004) 
observed positive adipogenic differentiation of the UCMS cells via Oil red-O staining.  
The cells were also positive for the adipocyte marker PPARγ2. 
 
Osteogenic Potential 
Osteogenic differentiation occurred after human UCMS cells were exposed to 
osteogenic medium for 3-4 weeks.  There was observed direct evidence of calcium 
deposits as the accumulation of cells began to increase.  Different proteins, including 
osteopontin, BSP-2, osteonectin, and osteocalcin were expressed in umbilical cord stem 
cells that successfully differentiated into osteocytes (Karahuseyinoglu et al., 2007).  In 
another study, after 28 days of culture in osteogenic differentiation medium, UCMS cells 
formed alkaline phosphatase-positive aggregates and were positive for von Kossa 
staining (Wang et al., 2004). The von Kossa stain indicates calcium in mineralized tissue. 
There was also expression of the osteogenic marker osteopontin in the newly 
differentiated osteocytes. 
 
Neuronal Differentiation 
UCMS cells also have the ability to become neuronal-like.  Karahuseyinoglu et al. 
(2007) induced hUCMS to become more neuronal like.  The hUCMS had rounding of 
their cell bodies that gave rise to thin extensions that touched each other to a certain 
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extent.  As the extensions became thinner it was apparent that bipolarization was 
occurring.  After 24 hours they spontaneously de-differentiated back into flat cells.    
Spontaneous de-differentiation is common in mesenchymal stem cells (Karahuseyinoglu 
et al., 2007).   
 
In another report, Salvia miltiorrhiza was added into the medium containing 
hUCMS and within 1-2 hours the morphology of these cells had a marked change (Lian 
et al., 2005).  Eight hours after the cells were in contact with the medium the cells 
became contracted, smaller and there were bipolar or multipolar prominences (Lian et al., 
2005).  The cells went from a basic fibroblast like morphology to a spherical, star-like or 
elongated appearance.  Multiple neurites extending from the cell body were observable 
after 24 hours of induction by Salvia miltorrhiza as well as long axon like processes.  In 
addition to morphological changes in the cells, there was also positive expression for the 
neuronal markers nestin, β-tubulin III, NF and GFAP.  Mitchell et al. (2003) were also 
able to differentiate umbilical cord stem cells into neuronal like cells and glia.  The 
differentiated cells expressed neuron-specific enolase (NSE), a specific marker for neural 
stem cells; the control stem cells expressed NSE as well however expression was lower 
(Mitchell et al., 2003).  Glial markers, GFAP and CNPase were observed in the 
differentiated cells and in the control cells in a lower amount (Mitchell et al., 2003).   
Wang et al. (2004) reported hUCMS have the ability to differentiate into 
cardiomyocytes in addition to chondrocytes, osteocytes and adipocytes. In the study, 5-
azacytidine was added to the medium of hUCMS and the drug induced changes the 
expression of cardiac troponin I and N-cadherin in the differentiated cells as compared to 
lower expression of these genes in untreated cells (Wang et al., 2004).   
 
Myogenic Differentiation 
hUCMS that are CD105 (+) have the ability to differentiate into skeletal muscle 
cells (Conconi et al., 2006).   Within 7 to 14 days after myogenic induction, the cells 
began to elongate and fused into multinucleated rudiments.  Around day-7 to day-16, 
Myf5 was expressed and at day-16 most of the multinucleated cells were positive for 
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Myo-D (Conconi et al., 2006).  Rats were used to observe the differential potential of 
CD105+ cells within injured tissue.  The tibialis anterior muscle of the rat was damaged 
using bupivacaine cholridate followed two days later by treatment with a myotoxic drug 
to induce an inflammatory response resulting in large necrotic areas.  The stem cells were 
injected into the rat tibialis anterior muscle to observe the effects of the cells in vivo.  In 
both the control and hUCMS treated animals the necrotic areas disappeared.  The animals 
that received hUCMS showed signs of flogosis but that decreased by day 14.  The cells 
were present in the muscle tissue until day 14 and the cells co-expressed sarcomeric 
tropomyosine (Conconi et al., 2006).  This study reveals that hUCMS have the potential 
to survive in vivo and contribute to the formation of muscle after injury when 
differentiated into skeletal myocytes. 
 
Endothelial Differentiation 
Endothelial differentiation of hUCMS was reported by (Wu et al., 2007).  
Induction was achieved by culture with VEGF and bFGF on Matrigel coated coverslips.  
Within 48 hours there was a vascular network.  In vitro, the ability of DiI-labeled ac-LDL 
to be taken up by the cell is a specific marker for endothelial cells.  About 30-50% of the 
cells expressed endothelial cell markers such as platelet endothelial cell adhesion 
molecule (PECAM), and CD34.  Endothelial cells are needed for many clinical 
applications including the vascularization of tissue-engineered grafts, anastomosis and 
treatment of ischemic tissues.  The cultured hUCMS were injected into an ischemic site 
in the left adductor muscle of nude mice 24 h after ischemia via ligation of the left 
femoral artery (Wu et al., 2007).  The stems cells incorporated into the murine 
vasculature.  The cells were labeled with DiI which detected anti-human CD34 antibody 
in the injection site and by 28 days after ischemia the hUCMS were differentiated into 
endothelial lineage cells. The study indicates that hUCMS cells have the ability to 
vascularize areas of ischemic tissue or injured tissue.  In order for tissue-engineered 
transplants to be successful the tissue has to be able to vascularize so that blood can flow 
in and out of the area.  Therefore the ability of hUCMS cells to differentiate in vitro into 
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endothelial cells is a major advance in regards to tissue engineering and re-
vascularization of injured tissues. 
 
Immunogenicity of UCMS Cells 
UCMS cells have a unique immunogenic profile that makes them candidates for 
tissue repair.    Cells may or may not possess major histocompatability complexes (MHC) 
I or II.  MHC antigens are displayed on cell surfaces and are responsible for lymphocyte 
recognition as well as antigen presentation.  The MHC can control the immune response 
through recognition of “self” and “non-self”. PUCS contain low amounts of MHC I and 
no MHC II (Cho et al., 2008).  The significance of this finding is that perhaps PUCS do 
not elicit an immune response.    There is evidence that the PUCS demonstrate a low 
immunogenic profile.  Cho et al., (2008) demonstrated this in his study using miniature 
swine umbilical cords that were haplotype mismatched.  SLAcc or SLAac animals had an 
immune response via production of an antibody when injected with SLAdd peripheral 
blood mononuclear cells (PBMCS). The sensitization occurred 3 weeks after the 
injection. When animals received an injection with the same dose of PUCs there was no 
detectable antibody directed toward SLAdd cells.  An immune response can be elicited 
when PUCs are activated by interferon gamma (IFN-γ). This is because PUCs activated 
by IFN-γ have increased MHC I surface expression and induced expression of MHC II 
(Cho et al., 2008).  
 
 
Unactivated PUCs injected in a complete freunds adjuvant (CFA) induced 
inflammatory lesion and were able to induce an immune response (Cho et al. 2008).  An 
immune response was also induced by injecting the unactivated PUCs into the same site 3 
times.  Another method that induced an immunogenic response by PUCs was through the 
use of haplotype mismatched skin grafts.  The skin graft donors were SLAdd animals.  
The graft skin was placed on SLAcc or SLAac animals that were injected with unactivated 
PUCs, activated PUCs and unactivated PUCs after CFA injection.  Pre-treatment with 
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unactivated PUCs resulted in rejection of the grafts within 5 to 6 days while all other 
groups had an accelerated rejection to the graft (Cho et al., 2008). 
Therefore a single injection of unactivated PUCs across a full MHC barrier does 
not elicit a detectable immune response.  The reduced immunogenicity seems to come 
from the lack of MHCII expression and the low MHCI expression.  The findings in the 
study suggest that perhaps precautions must be taken to avoid sensitization of the cell 
therapy product.  Administration of the cells into the same location a repeated amount of 
times may cause rejection of previously engrafted cells negatively affecting the benefits 
of the therapy.  UCMS cells have a low immunogenic profile, and this makes them a 
prime candidate for potential treatment of diseases. 
 
Parkinson’s Disease Therapy 
Dopaminergic neuronal loss results in Parkinson’s disease.  Both in vitro and in 
vivo, HUCS have the ability to differentiate into dopaminergic neurons (Weiss et al., 
2006 and Fu et al., 2006).  When the hUCMS are cultured with inducing medium they 
become positive for the catecholaminergic rate-limiting enzyme tyrosine hydroxylase 
(TH).  TH converts phenylalanine into dopamine.  The hUCMS differentiated into 
dopamine neurons, low yields of norepinephrine as well as GABAergic neurons (Fu et 
al., 2006).  hUCMS were transplanted into Sprague-Dawley rats that had their dopamine-
innervated striatum lesioned.  At 20 weeks after the cells were transplanted, cells labeled 
with bis-Benzimide were found in the striatum.  There was positive expression of TH as 
well.  The labeled hUCMS migrated approximately 1.4mm away from the implantation 
site. It was found that the rats treated with the hUCMS had less amphetamine induced 
rotation compared to the control group.  The significant finding of this study was that 
hUCMS can differentiate in vitro and positive effects of the cells were observed in vivo 
in rats with induced Parkinson’s disease.  The ability of the cells to improve the rats’ 
rotations gives hope for the use of the stem cells in clinical applications in human models. 
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Myocardial Differentiation 
UCMS cells may also prove therapeutically beneficial in the rat myocardial 
infarction model (Wu et al., 2007).  The study aimed at observing whether transplanted 
hUCMS could improve cardiac function in a rat model.  The rats underwent a ligation of 
the left coronary artery to mimic a myocardial infarction (Wu et al., 2007).  Rats with less 
than 60% left ventricular ejection fraction (LVEF) were randomized into two groups, a 
control group receiving phosphate buffered saline (PBS) and the hUCMS cell group.  At 
first, there was no difference between the two groups.  By 2 weeks after transplantation 
the LVEF improved with the hUCMS cell treated group.  The left ventricular dimensions 
of the stem cell group were significantly smaller than the control group.  The left 
ventricular posterior wall was thicker in the cell treated group compared to control group, 
(Wu et al., 2007).  The tissue samples from the cell treated group showed hUCMS cells 
within the infarct region.  Clusters of transplanted cells resided within the subepicardial 
and subendocardial infarct tissue.  Many hUCMS cells were found around capillaries and 
large vessels or arterioles (Wu et al., 2007).  Perhaps the hUCMS cells were either 
homing to the site of injury after transplantation, or possibly differentiating into 
endothelial type cells to help with revascularization.  In fact the hUCMS were positive 
for cardiac troponin-T, von Willebrand factor and smooth muscle actin suggesting that 
the hUCMS cells transdifferentiate into cardiomyocytes, smooth muscle cells, and 
endothelial cells (Wu et al., 2007).  The transplanted hUCMS cells also seemed to be 
secreting VEGF, an angiogenic cytokine. This study suggests that perhaps the hUCMS 
cells after transplantation differentiate into supporting cells around the injury site to help 
aid in the healing process. 
 
Treatment of Cerebral Ischemia 
Ischemia can be defined as loss of blood and oxygen to an area of the body.  
Therefore, cerebral global ischemia caused by cardiac arrest can lead to brain damage, 
specifically neuronal loss (Jomura et al., 2007).  A study conducted by Jomura et al. 
(2007) revealed the therapeutic benefits of using Oct-4 + rat umbilical cord stem cells 
(RUCMS) in rats with cerebral global ischemic damage.  The rats underwent cardiac 
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arrest (CA) and resuscitation to mimic the effects of real cerebral global ischemia.  The 
rats were put into four groups: Sham (A), 8 minutes CA without treatment (B), 8 minutes 
CA pretreated with defined media (C), 8 minutes pretreated with Oct-4+ RUCMS (D).  
The cells were injected into the hippocampus region of the brain.  It was observed that 
the group pretreated with Oct-4 + RUCMS had significantly lower neuronal damage 
compared to groups B and C.  The RUCM cells were observed underneath a fluorescent 
microscope where it was evident that the transplanted cells survived after the 
transplantation.  The cells actually migrated away from the injection site although no 
particular pattern of migration was noted in the study, perhaps the cells are homing to 
sites of injury.  The RUCM stem cells seem to differentiate in vivo after transplantation 
and could have migrated away from the site to aid in angiogenesis or even become 
neurons themselves.   
 
Retina Therapy 
A leading cause of blindness worldwide is tapetoretinal degeneration.  This is a 
group of inherited abnormalities in the retina involving the photoreceptors themselves or 
the cells that interact with the photoreceptors.  In the Royal College of Surgeons (RCS) 
rat, an animal model of photoreceptor degeneration, the use of human hUCMS, seems to 
provide a way to reduce the neurodegenerative outcome associated with the loss of 
photoreceptors (Lund et al., 2007).  The researchers compared the efficacy of hUCMS 
cells as well has human-placental derived cells (hPTC) and human bone marrow 
mesenchymal stem cells (hMSC).  The hPTCs were used as a comparable source to the 
hUCMS and hMSCs have been found to be biologically active in the retina.  The control 
consisted of human adult dermal fibroblasts (hADF) and media alone (Lund et al., 2007).  
The different cell sources were injected subretinal into the RCS rats and photoreceptor 
activities were tested by electroretinogram (ERG) responses at P60 and P90 and 
optomotor and luminance thresholds at P100.   
 
Rats that received hUCMS had achieved a low-level rescue of photoreceptors as 
indicated by the ERG a-wave responses, but it was not different from the sham group.  
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The hUCMS did have significantly better recovery of bipolar cells as indicated by the 
ERG mixed b-wave responsiveness as compared to sham and untreated rats (Lund et al., 
2007).  There was significant rescue of the rod and cone b-waves as compared to the 
shams as well.  At P90 the a-wave could still be elicited, but the b-wave amplitude had 
dropped.  The b-wave amplitude still held significance over the sham or untreated eyes.  
In the cell treated rats, measured acuity thresholds illustrated significant change from 
control levels during degeneration and after the cells were transplanted (Lund et al., 
2007).  Luminance threshold was measured as a way to indicate efficacy of cell treatment 
in local rescue of visual function.  The hUCMS treated rats retained normal retinal 
topographic order but the response sensitivity was not uniform.  The area that had the 
best luminance threshold was that of the retina, were the cells were injected.  Upon 
morphological examination of the retinas treated with hUCMS, there were no 
inflammatory reactions, pathologies or tumors found.  In fact it was found that the retinas 
injected with hUCMS had extensive photoreceptor rescue, about 30% of the retinal 
length.  The rods and cones were rescued as evident from the positive expression of 
arrestin, recoverin and mGlu96.  The cell numbers declined for about 2 weeks but were 
still seen at P100 (Lund et al., 2007).   
 
The hMSC treated group had some of the same responses and no significance 
when compared to the group treated with hUCMS.  Morphologically though, the hMSC 
group had poorer rescue than the hUCMS group.  The rescue area for the hMSC group 
was comparable to that of the sham group.    Eyes that were injected with hPTCs 
responded poorly and had restricted morphological rescue.  An ERG response could not 
be elicited at P90 for the hPTC group.  There was photoreceptor rescue at P100, although 
it was not as nearly as extensive as that of the hUCMS group.  Lastly, the hADF group 
had poor ERG responses and nothing was recordable by P90.  Also, no photoreceptor 
rescue was evident at P100 other than right at the injection site, and the appearance was 
similar to that of the control group (Lund et al., 2007). 
 
This study reveals that hUCMS can rescue rod and cone photoreceptors in the 
rodent model of retinal disease.  Something to consider is that the donor was human and 
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patient was rat, and no allogenic response was found.  Close observation of the animal 
model is needed to assure that there is no presence of teratomas and no allogenic 
reactions, for this can be problematic in a clinical setting.  The hUCMS injected into the 
rat may have neutrophic effects allowing the rescue of the photoreceptors, but not 
actually becoming one (Lund et al., 2007).  This is different than the other studies, where 
it was clearly observed that the hUCMS were differentiating into the tissue or cell type 
for which it was injected into.  The hUCMS may work via a diffuse mechanism and not a 
cell to cell contact mechanism. 
 
Umbilical cord stem cells have enormous promise in the area of cellular therapy 
and for clinical use.  The unique properties including, extensive passaging, in vitro and in 
vivo differentiation into specialized cell types, and low immunogenic profiles make them 
a candidate for use in a clinical setting and perhaps for agriculture applications as well.   
 
Agricultural Applications 
An agricultural use of UCMS cells is to create stem cell lines in each of the farm 
animal species.  As of now, there are not any established lines of ES cells available in the 
main farm animal species (Renard et al., 2007).  Perhaps the use of embryonic stem cells 
in farm animals will not be needed if UCMS lines are created.  The present interest in ES 
cells for farm animals is using somatic nuclear transfer for cloning (Renard et al., 2007), 
but there might be more promise in the use of UCMS, particularly for use as a delivery 
system for drugs or vaccines.  Many avenues can be researched in regards to UCMS cells 
and farm animals and each would benefit from a better understanding of the UCMS cells 
and their environment in Wharton’s jelly.   
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Table 1.1 Extracellular matrices that have been used as cell culture tools. 
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Matrix Composition GF&Cytokines Cells used 
with 
Effects on 
Cells 
References 
Matrigel Engelbreth 
Holm Swarm 
tumor 
TGF-b, FGF, 
tissue, 
plasminogen 
activator and 
others w/in 
EHS 
Tissue 
explants, 
stem cells, 
tumor cells 
 
 
 
Differentiation 
into specialized 
cell types 
Kleinman et 
al 2005 
Cartrigel Calf knee 
cartilage  
Media Rhesus 
monkey ES 
cell line 
(R366.4) 
chondrogenesis Philp et al 
2005 
Humatrix Human 
salivary and 
breast 
xenografts 
EGF, IGF-1, 
uPA 
Human 
myoepithelia
l tumor cell 
lines 
(salivary 
gland and 
breast) 
Tumorigenesis 
effect on 
salivary gland 
cells and 
decrease of 
invasion in 
breast cell lines 
Kedeshian et 
al 1998 
Polymer 
Scaffold 
50/50 blend 
of PLGA and 
PLLA 
Supplemented 
with IGF, RA, 
TGF-B, 
activin-A 
Human ES 
cell line 
Differentiation 
into 3D 
structures 
Levenberg 
et al 2003 
Hydrogel sIPNs Cultured on 
MEFs 
Human ES 
cell line  
HSF-6 
Remained 
undifferentiated 
Li et al 2006 
CHAPTER 2 - Effects of Extracellular Matrices on Porcine 
Umbilical Cord Matrix Stem Cells 
Introduction 
Extracellular matrices (ECMs) are ubiquitous structures that serve as scaffolds for 
cells and are comprised of secreted proteins and polysaccharides. The ECM provides 
structural support and helps regulate biological functions within tissues.  ECM plays a 
role in cell behavior, survival, development, adhesion, and migration as well as shape and 
function (Alberts et al., 2002).  ECM is the first complex substance to interact with stem 
cells and plays a role in regulating stem cell differentiation and self renewal (Philp et al., 
2005 and Chen et al., 2007).   
The discovery of stem cells in the loose connective tissue of the umbilical cord of 
pigs and other species (Mitchell et al., 2003) has focused attention on the characteristics 
of these unique cells. Much of the umbilical cord originates from extraembryonic 
mesoderm during embryonic development.  The umbilical cord contains two arteries and 
one or two veins depending on the species and is surrounded by amniotic epithelium. The 
central part of the cord is filled with a mucous substance termed Wharton’s Jelly that was 
first described by Thomas Wharton in 1656 (Sarugaser et al., 2005).  The jelly is 
composed of a variety of collagens, proteoglycans, mucopolysaccharides, and hyaluronic 
acid.  Its functions include regulation of blood flow and preventing the bending and 
closing of vessels (Alp Can et al., 2007; Sarugaser et al., 2005).  Wharton’s Jelly is a 
reservoir for a number of cytokines and growth factors including fibroblast growth 
factors, epidermal growth factor, insulin-like growth factor-1 and transforming growth 
factor- β (Sobolewski et al., 2005 and Malkowski et al., 2007).  The accumulation of 
growth factors and cytokines within the Wharton’s jelly undoubtedly plays a major role 
in regulating the physiology of the cells within it.  
An important concept in stem cell biology is the stem cell niche, a concept first 
proposed by Schofield (1978) for hematopoietic stem cells.  By definition, thestem cell 
niche in the umbilical cord must include a part or all of the Wharton’s jelly because it is 
the microenvironment in which umbilical cord matrix stem cells reside. The three 
transcription factors Nanog, Oct-4 and Sox-2 play a major role in embryonic stem cell 
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self-renewal and have been identified in porcine umbilical cord matrix stem cells (PUCs) 
(Carlin et al., 2006).   
In order to elucidate the mechanisms important for maintaining PUCs within 
Wharton’s jelly we sought to extract products from the jelly and apply them in vitro in 
ways that might recreate the niche from which the PUCS originated.  Specifically, a 
matrical gel termed Pormatrix (PMX) was prepared from the Wharton’s jelly of porcine 
umbilical cords.  We evaluated cell growth, relative gene expression of Nanog, Oct-4 and 
Sox-2, and the cell morphology and immunostaining for PUCs grown on Pormatrix, the 
commercial ECM product Matrigel, or plastic.  We also evaluated a low molecular 
weight filtrate of PMX that we refer to as flow through (FT) 
 
Materials and Methods 
Isolation of Wharton’s jelly 
Reagents and supplies were from Fisher Scientific (Fairlawn, NY) unless 
specified otherwise. During each farrowing cycle, approximately 40 to 50 porcine 
umbilical cords were obtained from postnatal piglets at the Kansas State University 
Swine Teaching and Research Center (STRC).  The umbilical cords were submerged in 
phosphate buffered saline (PBS, pH 7.4, Gibco, Grand Island, NY) that was 
supplemented with antibiotic/antimycotic solution (Sigma, St. Louis, MO) after they 
were obtained, approximately 30 min to 1 hour after birth and remained in the solution 
for 1 to 3 days at 4o C. Wharton’s jelly harvest began by cutting the cords into 5 cm 
segments and removing the blood vessels.  Mechanically, with the aid of hemostats and 
surgical scissors, Wharton’s jelly was removed from the de-veined cords.  The Wharton’s 
jelly was minced and placed in a sterile 50ml polypropylene centrifuge tube with PBS. 
The tissue was recovered by centrifugation for 20 minutes (800 X g, 4o C).  The PBS was 
removed and the Wharton’s jelly weighed. 
Preparation of Pormatrix 
PMX was prepared from Wharton’s jelly by extraction in 6M urea and 2 M 
guanidinium hydrocholoride (Gdn-HCl).  First Wharton’s Jelly was  homogenized in 
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2ml/g high salt buffer (3.4M NaCl ), 50mM Tris-HCl, 20mM EDTA, and 10mM N-ethyl-
maleimide (NEM, Sigma-Aldrich, St. Louis, MO) (pH 7.4) using a Tissue Tearor 
(Biospec Product, Inc Bartlesville, OK).  The homogenate was centrifuged in round 
bottom polypropylene tubes (Nalgene) for 15 minutes (12,000 X g, 4o C) using a JA-17 
motor that had been chilled to 4o C.  The supernatant was removed and discarded leaving 
a well defined pellet.  The pellet was extracted overnight by gentle stirring at 4o C in 
0.5ml/g of urea/Gdn-HCl extraction buffer, (6 M urea, 2 M Gdn-HCl, 50 mM Tris-HCl, 
20 mM EDTA, 10 mM NEM (pH 7.4) with an added 2mM dithiothreitol (DTT).  
Following protein extraction, the pellet was vortexed and the extract centrifuged (30 
minutes at 24,000 X g using a chilled rotor).  Tubes were placed on ice and the 
supernatant poured into a sterile 15ml polypropylene centrifuge tube.  The supernatant 
was placed into Specta/Por (MWcut off: 3,500) dialysis 3 membrane tubing, (Spectrum 
Laboratories, Inc, Rancho Dominguez, CA) and dialyzed  against 3 changes (24 
hours/change) of Tris-buffered saline (0.15M NaCl, 50mM Tris-HCl, 20mM EDTA, and 
10mM NEM at pH 7.4; 1L/change) at 4o C on a stir plate, followed by sequential dialysis 
against 0.5% chloroform and cell culture media (DMEM + Glutamax, Gibco).  After 
dialysis the supernatant was placed in a new 15ml polypropylene centrifuge tube and 
centrifuged at 4000 x g for 15 minutes.  The supernatant remaining is PMX. PMX was 
concentrated to a protein concentration of 2.44 to 3mg/ml using an iCON (Pierce 
Rockford, IL) concentrator (MW cut off 9,000 daltons) for 20 min at 5000 x g and 
protein concentration determined by Bradford Assay (Wallac Victor2 Perkin Elmer, 
Shelton, CT).  The filtrate was stored frozen (-20oC) until used.  At room temperature 
(RT) and 4o C the PMX remained liquid; but after for 1 hr 30 minutes at 37o C PMX 
underwent gelation.  
 
Experiment 1: Effect of gelling matrices on PUCs 
PMX was concentrated to 2.44mg protein/ml and underwent gelation upon 
incubation at 37oC.  The treatments were plated in triplicate in a 24-well plate (Costar 
Corning, NY).  The treatments were: gelling PMX, gelling PMX+FT, gelling Matrigel 
(prepared according to manufacturers directions, 9mg/ml), gelling Matrigel+FT, flow-
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through (FT), or on plastic as the control. FT is the solution that passes through the iCON 
concentrator. Cells were seeded into wells of a 24-well plate at a density of 18,000 
cells/well in 300μl of DMEM + Glutamax media supplemented with 20% fetal bovine 
serum (FBS) (Invitrogen), B-mercaptoethanol (55uM/ml, Sigma Aldrich), 25ug 
Gentamicin Sulfate (Sigma), and 100ug Normocin (InvivoGen, San Diego, California).  
The cells were incubated at 38.5oC in a 5% CO2 in air atmosphere. For each replicate 
when cells cultured on plastic reached 85 to 90% confluency (3 to 5d) all cells from each 
treatment were lifted using 1x trypsin + EDTA (Gibco) or Matrisperse (Becton Dickinson 
Labware, Bedford, MA) for PUCs grown on Matrigel.   The cells were counted for 
viability using trypan blue exclusion on a hemacytometer counting chamber (Hausser 
Scientific Partnership, Horsham, PA) and RNA was extracted. 
 
Experiment 2: Effect of non-gelling matrices on PUCs 
PMX and Matrigel were diluted to 1.2mg/ml to 1.5mg/ml protein using serum 
free DMEM + Glutamax.  FBS (20%) was added to each ECM supplemented medium 
and to control medium. PUCs were plated in 24-well plates in each of the three media, 
with 3 wells/treatment.  Each medium was tested with and without FT. Cells were seeded 
into each well at a density of 18,000 cells/well in 300μl of medium and incubated at 38.5o 
C and in 5% CO2 in air.  When cells cultured on plastic reached 85-90% confluency (3 to 
5d) all cells were lifted (trypsin + EDTA) or Matrisperse for those grown with Matrigel. 
PUCs from each treatment were counted for viability using the trypan blue exclusion test 
on a hemacytometer counting chamber and RNA was extracted. 
 
Experiment 3: Effect of passage number on gene expression in PUCS 
Sterile porcine umbilical cords were collected from the STRC.  The cords were 
placed in sterile 50ml polypropylene centrifuge tubes containing antibiotic/antimycotic 
PBS (pH 7.4) and transported to the laboratory.  Using sterile technique, the cords were 
cut into 1-3cm segments, and deveined.  The Wharton’s jelly was removed using surgical 
hemostats and scissors and minced into explants.  The explants were resuspended in 
complete media with 20% FBS and plated into flat bottom 6-well plates (Costar, Corning, 
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NY) and grown on plastic at 38.5o C and in 5% CO2 in air. After the explants attached 
and cell growth was established, the explants were removed using  trypsin + EDTA and 
discarded. The remaining cells were re-plated into 6-well plates and passaged when 85 to 
90% confluent for 6 passages.  At each passage, PUCs were counted using a 
hemacytometer counting chamber. Cells were re-plated at a density of 100,000 cells/well 
and remaining cells were used for RNA isolation using the RNeasy Micro Kit (Quiagen, 
Valencia, California).   
  
Immunocytochemistry 
Passage-8 PUCs were cultured on gelling PMX, non-gelling PMX, Matrigel, non-
gelling Matrigel, FT and plastic.  After 4 days of culture the cells were fixed with 10% 
formalin for 10 minutes at RT.  Using PBS, cells were washed 3 times at RT.  Fixed cells 
were permeabilized with 0.2% triton-x 100 (Sigma) at RT for 10 minutes.  Nonspecific 
binding sites in cells were blocked using 3% goat serum (Sigma) and 1% bovine serum 
albumin (BSA) (Sigma) in PBS for 30 minutes at RT.  The primary antiserum, rabbit 
anti-Nanog (Millipore, Billerica, MA) was diluted 1:500 in 0.5% blocking buffer (0.5% 
BSA in PBS pH 7.4) and incubated with the cells for 1 hour at RT.  After cells were 
incubated with primary antiserum they were washed 3 times with 0.05% Tween 20 (Bio 
Rad Laboratories) in PBS. The secondary antiserum (anti-rabbit IgG-Alexa-488, 
Invitrogen, Eugene, OR) was diluted 1:500 in PBS and incubated with cells for 1 hour at 
room temperature.  Cells were washed 3 times using 0.05% Tween 20/PBS after 
incubation with secondary antiserum and were  counterstained with 4’, 6-diamindino-2-
phenylindole (DAPI, Vector Laboratories, Inc, Burlingame, CA) and examined using 
fluorescence microscopy.  The filter used to observe Nanog stain (Alexa-488) was filter 
EF-4 FITC/GFP with excitation wavelengths from 490 to 520nm.  The filter used to 
observe the DAPI counterstain was the filter EF-4 UV-2A with excitation wavelengths 
from 330 to 380nm.  Images were captured using Hoffman optics and images recorded 
with a Nikon diaphot 300 digital camera. 
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RNA isolation and quantitative RT-PCR 
Total RNA was collected from PUCS after each passage from experiment 3 and 
collected from PUCS in experiment 1 and 2 after cells grown on plastic were 85 to 90% 
confluent.  In brief, PUC cells passaged on plastic or grown on PMX, FT and control 
were lifted using 1x trypsin (GIBCO) while PUC cells grown on Matrigel were lifted 
using Matrisperse (Becton Dickinson Labware, Bedford, MA).  A viability cell count was 
performed using the trypan blue exclusion test (Sigma) on a hemacytometer counting 
chamber.  The remaining cells were exposed to a lysis buffer supplied by the kit and 
transferred to an RNeasy column.  A DNase digest (RNase-free DNase Set, Qiagen) was 
performed to remove genomic DNA.  After washing, RNA was eluted from the column 
using 14 μl of nuclease-free water.  The RNA was measured using Nano-Drop (ND-1000 
Spectrophotometer, Wilmington, DE).  The isolated RNA underwent reverse 
transcription using Taq Man RT reagents (Applied Biosystems, Branchburg, NJ) in a 20 
μl reaction. 
 
The PUC cDNA was subjected to quantitative RT-PCR using Nanog, Sox-2, Oct-
4 and 18S ribosomal subunit primers (18S primer sequences were as follows: FWD: 5’-
GAGGTTCGAAGACGATCAGA-3’; REV: 5’-TCGCTCCACCAACTAAGAAC-3’; 
annealing temperature = 55oC).  The other primer sequences are as follows: Nanog FWD: 
5’-CCCGGGCTTCTATTCCTACCA-3’; REV: 5’-TACCCCACACGGGCAGGTT-3’; 
Sox-2 FWD 5’-TTCCATGGGCTCAGTGGTCAA-3’; REV: 5’-
TGGAGTGGGAAGAAGAGGTAAC-3’; Oct-4 FWD 5’-
AGAAGGATGTGGTCCGCGT-3’; REV: 5’-ACTGCTTGATCGTTTGCCC-3’, 
(Invitrogen).The reactions were assembled using 1μl of cDNA, 10μl of  power SYBR 
green master mix (Applied Biosystems, Fostercity, CA), 300 nM each of FWD and REV 
primers (Invitrogen) to make a 20μl reaction per well in a 96 well plate.  Relative 
expressions of Nanog, Oct-4, and Sox-2 were normalized to the 18s mRNA endogenous 
control.  
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Statistical Anaylsis 
 
Data were analyzed using the PROC Mixed procedure of SAS (SAS, 2000; SAS 
Inst. Inc., the Satterthwaite degrees of freedom).  The significance was declared at P<0.05 
and a trend at P=0.10 to P=0.06 unless noted otherwise.  When F-tests were significant, 
means were compared using Least Significance Difference procedure. 
Results 
Experiment 1: Effect of Gelling Matrices on PUCS 
Morphology and Cell Number. 
Morphology was observed using Hoffman optics and images recorded with a 
Nikon digital camera.  Cells cultured on plastic grew in a monolayer, and consisted of 
elongated fibroblastic cells as well as small colonies (Fig. 1D). Cells cultured on PMX 
were fibroblastic in shape and formed a monolayer with few colonies observed (Fig. 1A).  
The colonies were small with tightly packed cells.  The Matrigel treatment resulted in 
cells forming relatively larger colonies of tightly packed cells (Fig. 1B).  Cells grown on 
Matrigel differed from those cultured on other treatments in that they did not form a 
monolayer or have a fibroblastic appearance. The flow-through treatment resulted in cells 
with morphology similar to those cultured on plastic (Fig. 1c).  Fewer cells were 
harvested from PMX and Matrigel coated wells compared to plastic but FT did not 
(P>0.10) affect cell proliferation (Table 2.1).   
Relative Gene Expression of Nanog, Oct-4 and Sox-2 
The type of matrix and whether FT was added to the treatments affected (P<0.05) 
the expression of Nanog.  Addition of FT to PMX reduced Nanog expression for PUCs 
(Table 2.2).  PUCs cultured on Matrigel, Matrigel+FT, Plastic+FT and PMX expressed 
Nanog 4.46, 5.27, 4.28, and 4.43 fold higher, respectively, than PUCs cultured on 
PMX+FT. PUCs grown on different matrices tended (P=0.10) to differ in the expression 
of Oct-4 but not (P<0.10) in expression of Sox-2. 
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Experiment 2: Effect of Non-gelling Matrices on PUCS 
Morphology and Cell Number 
Cells cultured on plastic resulted in elongated fibroblastic cells and small colonies 
of tightly packed cells with well defined borders (Fig. 2D).  Compared to PUCs grown on 
plastic, cells cultured on non-gelling PMX had relatively larger colonies with well 
defined borders and tightly packed cells (Fig. 2A).  In addition to colonies there were 
elongated fibroblastic cells. PUCS cultured on non-gelling Matrigel formed a monolayer 
with small colonies (Fig. 2B).  FT treated cells were fibroblastic in shape with few 
colonies (Fig. 2C). Number of cells harvested differed (P<0.05) between the matrices 
because fewer cells were collected from Matrigel wells (Table 2.3). 
 
Relative Gene Expression of Nanog, Oct.4 and Sox 2 
Nanog gene expression tended (P=0.10) to differ due to the addition of FT (Table 
2.4).  Oct-4 did not differ (P>0.10) among the treatments regardless of matrix type or 
addition of FT.  Addition of FT to Matrigel tended (P=0.10) to increase Sox-2 expression 
and PUCs grown on Matrigel+FT expressed Sox-2 7 fold greater than those grown on 
PMX+FT (Table 2.5). 
 
Experiment 3: Passaging of PUCS 
Relative Gene Expression and Immunocytochemistry 
Quantitative RT-PCR was conducted to observe the relative gene expression of 
Nanog, Oct-4, and Sox-2 of PUCS over time (Table 2.6).  Expression of Nanog, Oct-4 
and Sox-2 did not (P>0.10) differ over passages 0 to 6.  PUCs at passage 8 that were 
cultured on gelling PMX, gelling Matrigel, non-gelling PMX, non-gelling Matrigel, FT, 
and plastic were all positive for the protein Nanog (fig. 3). Nanog was localized 
predominantly within the nuclei of the PUCs but there was some cytoplasmic staining 
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perhaps due to non-specific binding of the primary antibody or perhaps Nanog protein 
turnover.  Cells grown on nongelling Matrigel, that were clumped were more likely to be 
positive for Nanog than individual cells around the periphery (fig. 3g,h).   
 
Discussion 
PUCs are of interest due to their stem cell characteristics and the ease with which 
large numbers can be harvested and grown in vitro.  It has been observed that umbilical 
cord stem cells can differentiate into various mesenchymal cell types, neuronal cells and 
endothelial cells (Can et al., 2007).  PUCs have been shown to be minimally 
immunogenic (Cho et al., 2008) suggesting they may have applications as transplants 
with less concern of donor rejection.   
 
The three transcription factors Nanog, Oct-4 and Sox-2 are expressed at high 
levels in embryonic stem cells. These transcription factors regulate the expression of 
other genes during embryonic development and are found at high levels in pluripotent 
cells of the inner cell mass (Liu et al., 2007).  When these transcription factors are down-
regulated there is a loss of pluripotency and self-renewal and increased differentiation of 
the cells.  It has been shown that these three transcription factors are expressed in PUCs 
(Carlin et al., 2006).   
  
PUCs are located within Wharton’s jelly of the umbilical cord. The Wharton’s 
jelly is composed mainly of hyaluronic acid and collagens (Can et al., 2007).  Many 
growth factors and cytokines are harbored within Wharton’s jelly and many of these 
growth factors are known to regulate stem cell behavior. It can be suggested that 
Wharton’s jelly serves as a niche or microenvironment in which the PUCs reside but the 
mechanisms operating in this niche are unknown.   
  
Here we report attempts to re-create the Wharton’s jelly environment in vitro with 
the intention to study Wharton’s jelly effects on PUCs.  The ability to grow PUCs in an 
environment more similar to their in vivo milieu could be useful for studying the 
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physiology of PUCs and the interactions of PUCs with their extracellular matrix.  The 
Wharton’s jelly of the porcine umbilical cord was used to create PMX, a product that gels 
when the protein concentration is at least 2.44mg/ml and the temperature is 37°C.  In 
experiment one, PMX was compared to the gelled matrix Matrigel and plastic for effects 
on gene expression in PUCs.  In addition to these matrices we evaluated the effects of a 
low molecular weight filtrate collected during production of PMX.  We used PUCs at 
passages 3 to 5 for our studies and evaluation of the PUC isolates we used through 
passage 6 revealed that expressions of Nanog, Oct-4, and Sox-2 were stable over this 
interval. Therefore early-passage PUCs may provide an adequate in vitro model for 
evaluating the effects of Wharton’s jelly products on the expression of these genes in 
PUCs. 
 
We found that the gelled matrices reduced cell proliferation by PUCs and this was 
particularly apparent for Matrigel.  Cells grown on gelling Matrigel tended to form tight 
colonies similar to those formed by embryonic stem cells.  Matrigel also increased Nanog 
expression.  Gelled PMX had no effect on expression of the three genes studied, but 
when FT was added to gelled PMX the expression of Nanog mRNA was decreased.  
 
Culture in the presence of lower concentrations of the matrices that did not gel 
revealed no effects of the matrices alone (Exp. 2).  However when FT was added to 
cultures containing non-gelling concentrations of the matrix products or plastic there 
tended to be an increase in Nanog expression.  Sox-2 expression also tended to increase 
when PUCs were cultured on Matrigel+FT compared to Matrigel alone.  These effects of 
FT could be due to growth factors in FT that potentially regulate gene expression in 
PUCs.  We evaluated only one concentration of FT and only two concentrations of each 
matrix product in our experiments and we do not know the growth factors that are present 
in our PMX and FT products.  Further research will be required to assess the possible 
effects of other amounts of these products.  Based on literature reports of growth factors 
in Wharton’s jelly we speculate that FT could include TGF-β, IGF-1, bFGF and PDGF.  
Both TGF-β and IGF-1 are known to regulate embryonic stem cells of the ICM (Bendall 
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et al., 2007).   These proteins might be responsible for the effects of FT on PUCs but 
other unidentified components should also be evaluated. 
 
In conclusion we have prepared an extract of porcine Wharton’s jelly that 
supports attachment and growth of PUCs and identified a low molecular weight filtrate 
that stimulates expression of Nanog in vitro.  We suggest that further work in this area 
may provide an increased understanding of the environment provided by Wharton’s jelly 
and lead to improved methods for growing PUCs in vitro.   
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Morphology of PUCS Cultured on Gelling Matrices. 
PMX(A), Matrigel(B), FT(C), Plastic(D). Arrows indicate colonies of cells. 
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Figure 2. Morphology of PUCs Cultured on Non-Gelling Matrices.  
PMX(A), Matrigel(B), FT(C), Plastic(D). Arrows indicate representative colonies of 
cells. 
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Figure 3. Immunocytochemistry for PUCs grown on different matrices. 
DAPI A,C,E,G,J,K (PMX, Non-Gel PMX, Matrigel, Non-gel Matrigel, FT, Plastic respectively)  Nanog: B,D,F,H,I,L 
(PMX,Non-Gel PMX, Matrigel, Non-gel Matrigel, FT, Plastic, respectively) 
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Table 2.1 Effect of gelled matrices and a low molecular weight filtrate of  
Wharton’s jelly (FT) on proliferation of pig umbilical cord matrix stem cells. 
 
 
 
 
 
Treatment Plastic Matrigel Pormatrix SE 
n 3 3 3  
Cellsa 41167b 9458.3c 16083c 10031 
a Cells/3 wells of a 24-well plate. 
bcTreatments without a common superscript differ (P<0.05). 
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Table 2.2 Effect of gelled matrices and a low molecular weight filtrate of Wharton’s 
jelly (FT) on gene expression a in pig umbilical cord matrix stem cells. 
 
 
 
 
 
 
 
Treatment        Plastic         Matrigel        PMX SE 
n 3 3 3 3 3 3 
Gene - FT - FT - FT 
Nanog 17.8bc 17.0b 16.9b 16.7b 16.9b 19.1c 2.54 
Oct-4 21.6 21.1 21.9 23.2 20.6 21.4 1.85 
Sox-2 23.7 21.9 22.2 20.7 23.9 23.5 1.27 
 
a Δ CT= average cycle at threshold (CT) for the 18S housekeeping gene-average CT for 
the target gene. 
bc Means with different superscripts differ (P<0.05). 
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Table 2.3 Effect of non-gelled matrices and a low molecular weight  
filtrate of Wharton’s jelly (FT) on cell proliferation of pig umbilical  
cord matrix stem cell cells. 
 
 
 
  
 
Treatment Plastic Matrigel Pormatrix SE 
n 3 3 3  
Cellsa 43250b 8833.3c 22750c 11000 
a Cells/3 wells of a 24 well plate. 
 bc Treatments without a common superscript differ (P<.05). 
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Table 2.4 Effect of addition of a low molecular weight filtrate of Wharton’s jelly 
(FT) and non-gelled matrices on Nanog mRNA expressiona in pig umbilical cord 
matrix stem cells. 
a ΔCT=Average CT 18S-Average CT for the target gene. 
FT Plastic Matrig
el 
PMX SE 
n 3 3 3  
- 21.9 21.9 22.1 22.0+2.62 
+ 21.5 20.1 20.8 20.82+2.62* 
* Addition of FT tended (P= 0.10) to increase Nanog expression. 
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Table 2.5 Effect of non-gelled matrices and addition of a low molecular weight 
filtrate of Wharton’s jelly (FT) on Sox-2 mRNA expressiona in pig umbilical cord 
matrix stem cellsb. 
a ΔCT=Average CT 18S-Average CT target gene. 
Treatment Plastic Matrigel PMX SEM 
 - FT - FT - FT  
n 3 3 3 3 3 3   
 20.8 20.9 21.6 18.7 20.4 21.5 1.29 
 b A matrix x ft interaction tended (P=0.10) to affect Sox-2 expression. 
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Table 2.6 Effect of passage number on gene expressiona in pig umbilical cord matrix 
stem cells*. 
 
Passage 
Gene P0 P1 P2 P3 P4 P5 P6 SE 
Nanog 19.54 19.38 18.75 18.50 19.55 18.64 19.01 1.08 
Oct-4 25.14 24.50 24.97 23.90 25.16 24.67 24.21 1.02 
Sox-2 22.17 23.30 23.36 24.59 24.01 23.87 23.59 1.25 
a Δ CT=Average CT 18S-Average CT target gene. 
* No significant difference (P>0.05) for transcription factors between passages. 
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